Glaukos Corp (GKOS) financials
Glaukos revenue and earnings by year
Glaukos's revenue was $507 million in the fiscal year to December 31, 2025, up 32.3% from the year before. Net income was -$188 million, -37.0% of revenue. Since the fiscal year to December 31, 2016, revenue has grown 18.0% a year on average.
Fiscal years, each labelled by the calendar year it ended in.
Income statement, the last 10 fiscal years
| Fiscal year to | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 507 | 383 | 315 | 283 | 294 | 225 | 237 | 181 | 159 | 114 |
| Revenue growth | 32.3% | 21.9% | 11.3% | -3.8% | 30.7% | -5.1% | 30.7% | 13.8% | 39.2% | — |
| Gross profit | 283 | 289 | 239 | 214 | 227 | 133 | 198 | 156 | 138 | 98 |
| Gross margin | 55.7% | 75.5% | 76.0% | 75.6% | 77.3% | 59.2% | 83.7% | 86.2% | 86.8% | 85.9% |
| Operating income | -200 | -122 | -129 | -82 | -33 | -124 | -50 | -13 | -2 | 4 |
| Operating margin | -39.3% | -31.9% | -40.9% | -29.1% | -11.2% | -54.9% | -21.2% | -7.2% | -1.4% | 3.7% |
| Net income | -188 | -146 | -135 | -99 | -50 | -120 | 15 | -13 | -0 | 5 |
| Net margin | -37.0% | -38.2% | -42.8% | -35.1% | -16.9% | -53.5% | 6.5% | -7.1% | -0.1% | 4.0% |
| Diluted EPS | -$3.28 | -$2.77 | -$2.78 | -$2.09 | — | -$2.73 | — | -$0.38 | -$0.01 | $0.12 |
| Free cash flow | -39 | -68 | -78 | -63 | -23 | -30 | -5 | 9 | 20 | 6 |
Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open GKOS in Markets.
How Glaukos makes money
Revenue by segment in the quarter to September 30, 2026, as the company reports it.
| Segment | Revenue | Share |
|---|---|---|
| Glaucoma | $152M | 72.0% |
| Corneal Health | $59.0M | 28.0% |
See also: GKOS returns
No forecast, no recommendation. This page describes Glaukos Corp from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.